Brendan Luu Enanta Pharmaceuticals Inc (ENTA) insider trading activity

Brendan Luu is Chief Business Officer of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 38,329 shares of ENTA, which is worth approximately $462,247. The most recent transaction as insider was on Dec 05, 2025, when has been sold 1,394 shares (Common Stock) at a price of $14.23 per share, resulting in proceeds of $19,836. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.3K

4.7% 3M change

6.33% 12M change

Total Value Held $462,247

Brendan Luu Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 05 2025	SELL Open market or private sale	$19,836 $14.23 p/Share	1,394 Reduced 3.51%	38,329 Common Stock
Dec 01 2025	SELL Payment of exercise price or tax liability	$7,031 $14.12 p/Share	498 Reduced 1.24%	39,723 Common Stock
Feb 12 2025	SELL Payment of exercise price or tax liability	$18,592 $5.59 p/Share	3,326 Reduced 7.64%	40,221 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	7,500 Added 14.69%	43,547 Common Stock
Dec 06 2024	SELL Open market or private sale	$18,400 $8.06 p/Share	2,283 Reduced 5.96%	36,047 Common Stock
Dec 01 2024	SELL Payment of exercise price or tax liability	$6,475 $8.6 p/Share	753 Reduced 1.93%	38,330 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$12,074 $12.41 p/Share	973 Reduced 2.43%	39,083 Common Stock

Feb 12 2024	BUY Grant, award, or other acquisition	-	3,320 Added 7.65%	40,056 Common Stock
Dec 05 2023	SELL Open market or private sale	$20,463 $9.63 p/Share	2,125 Reduced 5.47%	36,736 Common Stock
Dec 01 2023	SELL Payment of exercise price or tax liability	$7,145 $9.49 p/Share	753 Reduced 1.9%	38,861 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$338,572 $52.77 p/Share	6,416 Reduced 13.94%	39,614 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	20,305 Added 30.61%	46,030 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$22,076 $44.33 p/Share	498 Reduced 1.9%	25,725 Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	18,500 Added 41.37%	26,223 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$30,558 $62.49 p/Share	489 Reduced 5.95%	7,723 Common Stock
Feb 14 2022	BUY Grant, award, or other acquisition	-	1,412 Added 14.67%	8,212 Common Stock
Nov 19 2021	BUY Grant, award, or other acquisition	-	6,800 Added 50.0%	6,800 Common Stock

Brendan Luu

Chief Business Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTA shares.

Notify only if

Value

Insider Trading

Get notified when an Enanta Pharmaceuticals Inc insider buys or sells ENTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to ENANTA PHARMACEUTICALS INC

Track Activities on ENTA

Account